2. European Patients’ Academy
on Therapeutic Innovation
Basics of hypothesis testing:
Null and alternative hypothesis
Sample size
Bias
Type I and Type II error
Significance
Power
Confidence intervals
Trial design types
2
The purpose and fundamentals of
statistics
3. European Patients’ Academy
on Therapeutic Innovation
A statistical hypothesis is an assumption about a
population parameter (a measurable characteristic of a
population).
Hypothesis testing is the evaluation done by a researcher
in order to either confirm or disprove a hypothesis.
Hypothesis tests typically examine a random sample from
the population. If sample data are not consistent with the
statistical hypothesis, the hypothesis is rejected.
Samples should be representative of the population,
however, hypothesis testing on samples can never
guarantee a hypothesis completely - only say that it has a
certain probability to be true or false.
3
What is hypothesis testing?
4. European Patients’ Academy
on Therapeutic Innovation
Null hypothesis (H0) - formulated to capture our current
situation. A null hypothesis in a clinical trial might be that
the new medicine is no better than the current treatment.
Alternative hypothesis (H1) - formulated to capture
what we want to show by doing the trial. An alternative
hypothesis in a clinical trial might be that the new
medicine is better than the current treatment.
4
Null and alternative hypothesis
5. European Patients’ Academy
on Therapeutic Innovation
Null hypothesis
is true
Null hypothesis
is false
Reject the null
hypothesis
Type I error
False positive
Correct outcome
True positive
Fail to reject the
null hypothesis
Correct outcome
True negative
Type II error
False negative
5
Type I and Type II error
6. European Patients’ Academy
on Therapeutic Innovation
Sample size is the total number of participants required
for a trial. It is based on the principles of statistical
hypothesis testing:
1. Magnitude of the effect expected
2. Variability in the variables being analysed
3. Desired probability
6
Sample size
7. European Patients’ Academy
on Therapeutic Innovation
A randomly selected study sample may not be
representative of the true population.
By using larger study samples the severity of sampling
error can be reduced.
7
Sampling error
8. European Patients’ Academy
on Therapeutic Innovation
Bias is the intentional or unintentional adjustment in the
design and/or conduct of a clinical trial, and analysis and
evaluation of the data that may affect the results.
An example of bias: when examining patients, a doctor
looks more favourably towards patients receiving the
actual medicine instead of the placebo.
8
Bias
9. European Patients’ Academy
on Therapeutic Innovation
Significance level is the probability of committing a type I
error.
Factors that affect significance level are:
The power of the test
Size of sample
9
Significance level
10. European Patients’ Academy
on Therapeutic Innovation
The probability of not committing a type II error is called
the 'power' of the hypothesis test.
Factors that can increase the power:
Increasing sample size
Higher significance level
10
Power
11. European Patients’ Academy
on Therapeutic Innovation
The 'confidence interval' is used to express the degree of
uncertainty associated with a sample statistic.
11
Confidence interval
12. European Patients’ Academy
on Therapeutic Innovation
There are several types of statistical tests that can be
used for hypothesis testing:
z-test: used to test hypothesis about a population mean when
the population variance is known.
t-test: tells if there is a significant difference between two sets of
data.
Chi-squared test: used to determine if two variables are related.
12
Common hypothesis tests